Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
about
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiesPurified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPHPlatelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cellsIsolation and characterization of human apolipoprotein M-containing lipoproteinsDirected evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specializationIncreased influence of genetic variation on PON1 activity in neonates.Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsThe human paraoxonase gene cluster as a target in the treatment of atherosclerosisInflammation, infection, cancer and all that…the role of paraoxonasesCaenorhabditis elegans paraoxonase-like proteins control the functional expression of DEG/ENaC mechanosensory proteins.Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.Paraoxonase 1 polymorphism and prenatal pesticide exposure associated with adverse cardiovascular risk profiles at school ageParaoxonase 1 activities and polymorphisms in autism spectrum disordersClinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosisHuman paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological rolesInduction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirinIdentification of paraoxonase 3 in rat liver microsomes: purification and biochemical propertiesAn assessment of antioxidant status in patients with carbon monoxide poisoningBeneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanismsA Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal StudyPLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activityIn vivo administration of BL-3050: highly stable engineered PON1-HDL complexesAscorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxonase-1 induction in cultured hepatocytes - role of the redox-regulated transcription factor Nrf2.Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK ratOxidative risk for atherothrombotic cardiovascular disease.Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation.The role of oxidative stress in atherosclerosis: the hope and the hypeOxidative profiles of LDL and HDL isolated from women with preeclampsia.Paraoxonase genes and disease.Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3.Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase.High density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis.Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endotheliumParaoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue.Is alcohol beneficial or harmful for cardioprotection?Estradiol enhances cell-associated paraoxonase 1 (PON1) activity in vitro without altering PON1 expression.The genetics of vascular complications in diabetes mellitus.Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients.
P2860
Q24298200-B2590D07-DC85-4B52-8E32-69A1CBD177B4Q24302314-0B57E6C7-2CBF-4F04-84BE-B1104F433C13Q24323257-8852D3E6-BA32-4CD8-8D77-EF9C353C41FAQ24336276-A4B1A47D-56DD-4FAB-B5B6-3A85B9CCBDAAQ24598027-9A8F69EA-2626-472F-B2E1-4C0546AC2C8EQ24815868-9D285875-1B3D-4111-AC1D-4E09DB6104F0Q26774903-87693317-9C63-4E99-A971-3046E460A3EDQ26824356-E6871E01-C84E-4A61-A871-67B8425DEC00Q26849832-E1724687-2793-477C-9D6A-3446E8AF3030Q27305177-7C3A9623-C8DB-4845-ACAE-348792ED6314Q28364175-1421A7E3-53F6-4C19-9E35-90D4F30F04ECQ28384449-554AB447-953B-450C-B6B8-D23F17DEE750Q28390802-8DD7BFF0-386B-4320-BCD6-AAB4D3E3B1FEQ28392768-2269436F-7F6B-4655-809B-598F2BCDEC8EQ28395898-61E0375A-B1B8-4D97-A386-3C3757FBA2BCQ28570302-D8013B67-27EC-46FF-AB8A-62A38A315CDCQ28578200-35CD95AE-4023-41F9-9580-658AF808CA72Q28654645-577B8B52-8580-44BB-A0D2-2CD1759794C6Q30360076-120167FA-6DAF-4383-8816-9388F61A53E3Q30381312-9FAE0E65-8DD1-49FB-8DB1-EB3D1CD8C56CQ30655573-7AF24A2D-23D1-4F6E-8808-965E37F82090Q30891417-8B2E8CD0-62D0-4DC3-94BD-398902548D41Q30993830-F610104A-BF78-4A4A-B839-14AF88D02F3AQ33278805-914C326F-28E0-4AA8-878F-1DABA87E66FFQ33497323-B1A6D874-8B76-4754-9546-629D11B0C89DQ33501717-C2903C14-BAA5-4913-B268-93B2A2DD046EQ33554184-DF9B571E-3FFA-43C4-B8C3-33820EFC6EA9Q33587302-7193A7B9-7676-4010-B312-17CA03CC7D5AQ33645001-E81C9D94-A445-4301-971C-9C72EEB29DD6Q33696773-9CB602EA-A5F6-4F3E-984D-D6F8A66D2F63Q33708692-79704D94-1907-4994-B3A1-473EDBE5B4C1Q33742998-7F497FCA-DCEC-4FCF-8C0B-1B3B360F8D47Q33760697-3EBA8A4B-D1B9-4BDC-BFA4-4CA8EC2E7EFEQ33806840-BD314C36-338D-4F43-819B-026ADFD06AAEQ33853451-2B9CD2AA-FA14-425F-A2E2-9DDF57454EFAQ33902049-98272DC5-6AC2-4D13-A4A7-94BCFE4102B6Q33911138-F1306286-82B1-49E3-B812-C03E65AAC0F2Q33976196-10671EF4-20FA-4BB9-AD18-83B44E93CCD0Q33995879-E49EFF8B-C491-48D9-9801-ACF5E39879D3Q34011460-86F05A0C-0A8A-4264-B0CB-CB62A65BDF30
P2860
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Paraoxonase inhibits high-dens ...... xidative role for paraoxonase.
@en
Paraoxonase inhibits high-dens ...... xidative role for paraoxonase.
@nl
type
label
Paraoxonase inhibits high-dens ...... xidative role for paraoxonase.
@en
Paraoxonase inhibits high-dens ...... xidative role for paraoxonase.
@nl
prefLabel
Paraoxonase inhibits high-dens ...... xidative role for paraoxonase.
@en
Paraoxonase inhibits high-dens ...... xidative role for paraoxonase.
@nl
P2093
P2860
P356
P1476
Paraoxonase inhibits high-dens ...... xidative role for paraoxonase.
@en
P2093
Bisgaier CL
Primo-Parmo SL
Rosenblat M
P2860
P304
P356
10.1172/JCI1649
P407
P577
1998-04-01T00:00:00Z